Capital Research Global Investors’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $17.3M | Buy |
|
|||||
|
2017
Q3 | $20.2M | Buy |
|
|||||
|
2017
Q2 | $17.3M | Buy |
|
|||||
|
2017
Q1 | $17.1M | Sell |
|
|||||
|
2016
Q4 | $892M | Sell |
|
|||||
|
2016
Q3 | $1.88B | Sell |
|
|||||
|
2016
Q2 | $2.99B | Sell |
|
|||||
|
2016
Q1 | $3.84B | Hold |
|
|||||
|
2015
Q4 | $5.27B | Buy |
|
|||||
|
2015
Q3 | $4.29B | Buy |
|
|||||
|
2015
Q2 | $4.76B | Buy |
|
|||||
|
2015
Q1 | $4.29B | Buy |
|
|||||
|
2014
Q4 | $4.49B | Buy |
|
|||||
|
2014
Q3 | $4.02B | Buy |
|
|||||
|
2014
Q2 | $3.79B | Buy |
|
|||||
|
2014
Q1 | $3.57B | Sell |
|
|||||
|
2013
Q4 | $3.15B | Buy |
|
|||||
|
2013
Q3 | $2.58B | Buy |
|
|||||
|
2013
Q2 | $1.98B | Buy |
|